The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 04 Jul 2017
At a glance
- Drugs Liraglutide (Primary)
- Indications Diabetes mellitus
- Focus Therapeutic Use
- 31 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 27 Apr 2016 Planned End Date changed from 1 Sep 2015 to 1 Dec 2016.
- 27 Apr 2016 Status changed from recruiting to active, no longer recruiting.